Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
Public ClinicalTrials.gov record NCT00671476. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Intraductal Therapy of DCIS: A Presurgery Study
Study identification
- NCT ID
- NCT00671476
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Dr. Susan Love Research Foundation
- Other
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Interventions
- DNA methylation analysis Genetic
- TdT-mediated dUTP nick end labeling assay Genetic
- breast duct lavage Procedure
- fluorescence in situ hybridization Genetic
- immunoenzyme technique Other
- immunohistochemistry staining method Other
- laboratory biomarker analysis Other
- loss of heterozygosity analysis Genetic
- neoadjuvant therapy Procedure
- pegylated liposomal doxorubicin hydrochloride Drug
- polymerase chain reaction Genetic
- therapeutic conventional surgery Procedure
Genetic · Procedure · Other + 1 more
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2008
- Primary completion
- Jan 31, 2011
- Completion
- Not listed
- Last update posted
- Jan 9, 2014
Started 2008
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph Hospital | Eureka | California | 95501 | Recruiting |
| Doctor Susan Love Research Foundation | Santa Monica | California | 90403 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00671476, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 9, 2014 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00671476 live on ClinicalTrials.gov.